跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ARIPIPRAZOLE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ARIPIPRAZOLE
Authorized
STANDARD
ARIPIPRAZOLE
sivem pharmaceuticals ulc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
36ae6b649a4d6deb
Company
sivem pharmaceuticals ulc
Type
Standard
Approval Details
Approval Id
36ae6b649a4d6deb
Drug Approval Canada Name
ARIPIPRAZOLE
Product Name
ARIPIPRAZOLE
Status
Marketed
Status Date
2023-07-20
Original Market Date
2023-07-20
Din
02534363
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:16.08.04
Atc Original
N05AX12 ARIPIPRAZOLE
Atc Name
n 05 ax 12
Aig Number
0152514004
Company Name
sivem pharmaceuticals ulc
Company Address
4705 Dobrin Street, Saint-Laurent, Quebec, Canada, H4R 2P7
Active Ingredients
ARIPIPRAZOLE
20 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
36ae6b649a4d6deb
Type
Standard
Back to Health Canada Approvals